Nath Bio-Genes (India) Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|
| Revenue | 37.35 | 32.26 | 244.01 |
| Operating Expense | 29.36 | 25.63 | 206.82 |
| Net Profit | 2.66 | 2.89 | 33.89 |
| Net Profit Margin | 7.12 | 8.96 | 13.89 |
| Earning Per Share | 1.34 | 1.46 | 17.77 |
| EBIDTA | 8 | 6.63 | 37.21 |
| Effective Tax Rate | 14.27 | -0.45 | 0.67 |
| Particulars | Dec 2024 |
|---|---|
| Revenue | 37.35 |
| Operating Expense | 29.36 |
| Net Profit | 2.66 |
| Net Profit Margin | 7.12 |
| Earning Per Share | 1.34 |
| EBIDTA | 8.00 |
| Effective Tax Rate | 14.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 332.62 | 301.29 | 278.36 |
| Operating Expenses Annual | 282.24 | 252.40 | 241.13 |
| Operating Profit Annual | 54.49 | 49.45 | -49.69 |
| Interest Annual | 9.10 | 10.12 | 10.61 |
| Depreciation | 1.66 | 1.37 | 1.48 |
| Net Profit Annual | 40.18 | 35.17 | -67.34 |
| Tax Annual | 1.95 | 1.15 | 3.95 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 332.62 |
| Operating Expenses Annual | 282.24 |
| Operating Profit Annual | 54.49 |
| Interest Annual | 9.10 |
| Depreciation | 1.66 |
| Net Profit Annual | 40.18 |
| Tax Annual | 1.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 37.98 | 4.17 | 29.22 |
| Cash Flow from Operations | 74.72 | 38.37 | 17.05 |
| Cash Flow from Investing | -27.40 | -2.88 | -19.87 |
| Cash Flow from Financing | -9.81 | -1.67 | -22.23 |
| Cash Flow at the End | 75.50 | 37.98 | 4.17 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 37.98 |
| Cash Flow from Operations | 74.72 |
| Cash Flow from Investing | -27.40 |
| Cash Flow from Financing | -9.81 |
| Cash Flow at the End | 75.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 16.41 | 16.44 | 14.05 |
| PBIT Margin (%) | 15.43 | 15.44 | 12.95 |
| PBT Margin (%) | 13.75 | 13.93 | 11.73 |
| Net PROFIT Margin (%) | 12.08 | 11.67 | -24.19 |
| Return On Networth / Equity (%) | 6.79 | 6.31 | 4.12 |
| Return On Networth /Employed (%) | 7.31 | 7.06 | 5.32 |
| Return On Assets (%) | 5.68 | 5.37 | -9.92 |
| Total Debt / Equity (X) | 0.18 | 0.18 | 0.17 |
| Asset Turnover Ratio (%) | 0.47 | 0.46 | 0.41 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 16.41 |
| PBIT Margin (%) | 15.43 |
| PBT Margin (%) | 13.75 |
| Net PROFIT Margin (%) | 12.08 |
| Return On Networth / Equity (%) | 6.79 |
| Return On Networth /Employed (%) | 7.31 |
| Return On Assets (%) | 5.68 |
| Total Debt / Equity (X) | 0.18 |
| Asset Turnover Ratio (%) | 0.47 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 249.45 | 244.38 | 244.89 |
| Total Current Assets Annual | 568.52 | 520.99 | 467.80 |
| Non Current Assets Annual | 308.57 | 271.98 | 271.74 |
| Total Shareholders Funds Annual | 610.66 | 573.35 | 541.97 |
| Total Assets Annual | 877.08 | 792.97 | 739.54 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 249.45 |
| Total Current Assets Annual | 568.52 |
| Non Current Assets Annual | 308.57 |
| Total Shareholders Funds Annual | 610.66 |
| Total Assets Annual | 877.08 |
EPS (INR)
Expected
1.39
Reported
1.33
Surprise
-4.32%
Sep 2024
EPS beaten by -4.32%
Jun 2024
EPS beaten by -8.62%
Mar 2024
EPS beaten by -0.34%
